M&A Deal Summary

AGC Acquires AGC Biologics

On December 20, 2016, AGC acquired life science company AGC Biologics from Monitor Clipper Partners and EEP Advisers for 60.0B JPY

Acquisition Highlights
  • This is AGC’s 1st transaction in the Life Science sector.
  • This is AGC’s 0th largest (disclosed) transaction.
  • This is AGC’s 1st transaction in Denmark.
  • This is AGC’s 1st transaction in Washington.

M&A Deal Summary

Date 2016-12-20
Target AGC Biologics
Sector Life Science
Buyer(s) AGC
Sellers(s) Monitor Clipper Partners
EEP Advisers
Deal Type Add-on Acquisition
Deal Value 60.0B JPY

Target

AGC Biologics

Bothell, Washington, Denmark
website
AGC Biologics is a global contract manufacturing and development (CDMO) company for biopharmaceuticals. AGC Biologics is based in Bothell, Washington.

Search 195,853 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AGC

Tokyo, Japan

website


Category Company
Founded 1907
Sector Manufacturing
Employees55,999
Revenue 1.70T JPY (2021)
DESCRIPTION

AGC is a manufacturer and seller of glass, electronic materials, chemicals, and ceramics. AGC was incorporated in 1907 and is based in Tokyo, Japan.


DEAL STATS #
Overall 14 of 15
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 6 of 6
State (Washington) 1 of 1
Country (Denmark) 1 of 1
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-14 Vinythai Public

Rayong, Thailand

Vinythai Public Co. Ltd. is a sales and manufacturer of chemicals products. Vinythai Public Co. Ltd. was established in 1988 and is headquartered in Rayong, Thailand.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-04 Malgrat Pharma Chemicals SLU

Barcelona, Spain

Malgrat Pharma Chemicals SLU has extensive experience in manufacturing cGMP (* 3) marketed synthetic pharmaceuticals as well as compounds in clinical development at different scales.

Buy -

Seller(S) 2

SELLER
DESCRIPTION

Monitor Clipper Partners (MCP) is a private equity group formed by consulting firm The Monitor Group and private equity firm The Clipper Group. MCP targets private equity investments in middle-market companies in North America and Western Europe and looks to commit $10 to $70 million of equity per transaction. MCP does not focus on any particular sector but current portfolio companies suggest an interest in business services, natural/organic foods, specialty retail, health care services, gaming, logistics, mortgage technology, marketing services, financial services and metals. The Firm will consider both control and minority positions. Monitor Clipper Partners was formed in 1998 and is based in Cambridge, Massachusetts with additional offices in Zurich, Switzerland, Toronto, Canada, Luxembourg and London, United Kingdom.


DEAL STATS #
Overall 29 of 35
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 13 of 15
State (Washington) 1 of 1
Country (Denmark) 1 of 1
Year (2016) 2 of 2
Size (of disclosed) 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-24 The Access Group

Berkeley Heights, New Jersey, United States

The Access Group is a provider of marketing and advertising services to pharmaceutical, biotechnology and other health care clients. The Access Group offers pharmaceutical companies specialized expertise and capabilities that define and communicate drug therapies' value proposition to payers; educate the medical community on new drugs; and create and execute strategies that brand and market their products.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-01 Market Force

Peachtree Corners, Georgia, United States

Market Force is a global provider of customer experience management software and services, which capture customer experience data through multiple channels and provide location-based measurement and analytics. Market Force integrates this data into a cloud-based platform where clients can view, track, and analyze data in real time. Market Force was founded in 2005 and is based in Peachtree Corners, Georgia.

Sell -
DESCRIPTION

EEP is a Venture Capital investment firm that provides both dedication and passion on top of the financial investment itself. With more than 25 years of investment experience in life sciences, EEP provides deep sectorial knowledge and an established network. EEP was founded in 1999 and is based in London, England.


DEAL STATS #
Overall 4 of 5
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 3 of 4
State (Washington) 1 of 1
Country (Denmark) 1 of 2
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-09 Prenax

Courbevoie, France

Prenax provides an outsourced procurement and management service for subscription-based resources to companies and institutions globally, supported by premium, dedicated customer service and a user-friendly platform. Prenax was formed in 1993 and is based in Courbevoie, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-02 Bactolife

Copenhagen, Denmark

Bactolife develops novel biological solutions to reduce the risk of gastrointestinal infections in humans and animals. Antimicrobial resistance development is a major and increasing threat to human health worldwide. Bactolife was founded in 2017 and is based in Copenhagen, Denmark.

Buy -